Atıf İçin Kopyala
Rost N. S., Giugliano R. P., Ruff C. T., Murphy S. A., Crompton A. E., Norden A. D., ...Daha Fazla
STROKE, cilt.47, sa.8, ss.2075-2082, 2016 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
47
Sayı:
8
-
Basım Tarihi:
2016
-
Doi Numarası:
10.1161/strokeaha.116.013540
-
Dergi Adı:
STROKE
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.2075-2082
-
Anahtar Kelimeler:
atrial fibrillation, clinical trial, hemorrhage, risk factors, stroke, PREDICTING STROKE, HEMORRHAGE, METAANALYSIS, RIVAROXABAN, PREVENTION
-
Gazi Üniversitesi Adresli:
Evet
Özet
Background and Purpose-Patients with atrial fibrillation and previous ischemic stroke (IS)/transient ischemic attack (TIA) are at high risk of recurrent cerebrovascular events despite anticoagulation. In this prespecified subgroup analysis, we compared warfarin with edoxaban in patients with versus without previous IS/TIA.